申请人:MERCK & CO. INC.
公开号:EP0411909A1
公开(公告)日:1991-02-06
Compounds selected from the group consisting of imidazoles having the general formula (I)
or their acid addition salts, and imidazolium salts having the general formula II
wherein
R is OR′ or NR˝ R‴
R¹ is lower alkyl, benzyl;
R² is hydrogen, lower alkyl, or cycloalkyl;
R³ is hydrogen, lower alkyl, or cycloalkyl; or
R² and R³ taken together form an alkylene chain of 3 to 10 carbon atoms;
R⁴ is lower alkyl, benzyl;
X is an anion of a pharmaceutically acceptable salt;
m is 0 or 1; and
n is from 0 to 3;
provided that when n is 0, m is 0.
The compounds of general formulas I and II exhibit transglutaminase inhibiting activity and are useful in the treatment of thrombosis.
选自由通式为(I)的咪唑类化合物或其酸加成盐,以及通式为(II)的咪唑鎓盐。
或其酸加成盐,以及通式为 II 的咪唑鎓盐所组成的组中选出的化合物。
其中
R 是 OR′ 或 NR˝ R‴
R¹ 是低级烷基、苄基;
R² 是氢、低级烷基或环烷基;
R³ 是氢、低级烷基或环烷基;或
R² 和 R³ 共同形成 3 至 10 个碳原子的亚烷基链;
R⁴ 是低级烷基、苄基;
X 是药学上可接受的盐的阴离子;
m 是 0 或 1;以及
n 为 0 至 3;
但当 n 为 0 时,m 为 0。
通式 I 和 II 的化合物具有转谷氨酰胺酶抑制活性,可用于治疗血栓形成。